Search
for
Sort by
Research 601–630 of 1000+
- NON-PSORALEN TREATMENT OF VITILIGO. PART II. LESS COMMONLY USED AND EXPERIMENTAL THERAPIES
- Follicular unit extraction hair transplant harvest: a review of current recommendations and future considerations
- Female pattern hair loss
- Idiopathic hirsutism: excessive bodily and facial hair in women
- Inflammatory perifollicular fibrosis and alopecia
- Frontal fibrosing alopecia
- THERAPEUTIC HOTLINE: Treatment of androgenic alopecia with finasteride may result in a high grade prostate cancer in patients: fact or fiction?
- Copious Pre‐Ejaculation: Small Glands—Major Headaches
- Treatment-resistant giant unilateral Bowen’s disease of the scalp responding to radiotherapy
- Proscar and Propecia—A Therapeutic Perspective
- Clinicopathological characteristics and treatment outcomes of fibrosing alopecia in a pattern distribution: A retrospective cohort study
- Frontal Fibrosing Alopecia: An Update on Epidemiology and Treatment
- The postfinasteride syndrome; an overview
- Cell-Based Model Systems for Validation of Various Efficacy-Based Claims for Cosmetic Ingredients
- Nonscarring alopecias
- Male androgenetic alopecia
- Hairless or fertile? Finasteride leads to epididymal changes and infertility in rats
- Evaluation of men on finasteride.
- Updates on Hirsutism: A Narrative Review
- Managing Dermatologic Effects of Gender-Affirming Therapy in Transgender Adolescents
- Dermatologic care of patients with differences of sex development
- Current issues on the genetic implications and treatment of androgenic alopecia
- Adverse Effects of 5-Alpha Reductase Inhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern?
- Introduction to: Endocrinological aspects of andrology—what is new?
- The role of exosomes in follicle regeneration of androgenic alopecia
- Saw palmetto extract: A dermatologist's perspective
- Finasteride prescribed for hair loss consistently leads to depression. Comment on ‘Depression risk of 5-alpha reductase inhibitors: impact of active-comparator versus non-drug user control groups on risk measurement’
- PRP vs 5% topical Minoxidil: a dilemma in moderate male androgenetic alopecia
- Hair aging as an urgent problem of modern medicine
- Finasteride and Dutasteride in the Treatment of Androgenetic Alopecia: Risk or Benefit?